TGC Ventures International, Inc.
TGVN
Other OTC0.00
USD
- -
- -
ISIN
US8724182071
Return %
Stock
S&P500
1Y
- -
15.98
3Y
- -
62.25
5Y
- -
67.55
Capital Structure
FRC
•
in mil. unless spec.Working Capital
FRC
•
in mil. unless spec.Growth Rates
FRC
•
in mil. unless spec.Quarterly Revenue
FRC
•
in mil. unless spec.Quarterly Earnings Per Share
FRC
•
in mil. unless spec.Quarterly Dividends Per Share
FRC
•
in mil. unless spec.- CEO
- Michael Woo
- Sector
- Healthcare
- Industry
- Medical - Distribution
- Address
- 1170 Peachtree Street NE Atlanta GA United States of America 30309
- IPO Date
- Nov 3, 2014
- Similar Companies
- Business
- TGC Ventures International, Inc. TGC Ventures International, Inc. (TGVN) operates early detection cancer clinics that utilize infra-red thermal imaging technology to identify structural changes for breast cancer diagnosis and other applications; the company functions as a medically related holding entity providing health care services and medical devices targeted at healthcare providers and patients seeking non-invasive screening options. Its primary offerings center on clinic-based diagnostic services leveraging thermal imaging for early-stage cancer detection, with operations focused on the United States healthcare market. Established prior to its public listing on OTC markets, the company maintains a low market capitalization profile with approximately 1.20 million shares outstanding and no recent public disclosures of headquarters location or significant geographic expansions beyond domestic activities. No major acquisitions, partnerships, funding rounds, new product launches, or strategic shifts have been reported in the last 1-2 years, reflecting a stable but minimally active operational posture amid sparse recent news coverage [-37].